Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/30/2025

Community-Acquired Pneumonia Etiology

Pathogen Frequency

  • The American Thoracic Society suggests that Streptococcus pneumoniae is a common cause of community-acquired pneumonia (9-20% of episodes) 3, 4
  • Mycoplasma pneumoniae is also a common cause of community-acquired pneumonia (13-37% of episodes) 3, 4
  • Respiratory viruses are detected in up to 36% of community-acquired pneumonia cases 4, 5
  • Haemophilus influenzae is a common cause of community-acquired pneumonia, especially in smokers 3
  • The Infectious Diseases Society of America recommends considering less common pathogens, such as Legionella spp., Mycobacterium tuberculosis, and endemic fungi, in community-acquired pneumonia cases 3

Patient Population

  • In outpatients without cardiopulmonary disease, Streptococcus pneumoniae, Mycoplasma pneumoniae, and Chlamydia pneumoniae are common causes of community-acquired pneumonia 3, 4
  • In hospitalized patients, Streptococcus pneumoniae, Haemophilus influenzae, and atypical pathogens (Mycoplasma, Chlamydia, Legionella) are common causes of community-acquired pneumonia 1, 5, 6

Mixed Infections

  • Mixed infections (bacteria + virus or bacteria + atypical pathogen) are common, representing approximately 3-10% of cases 1, 6

Fungal Infections

  • Endemic fungi (such as histoplasmosis, coccidioidomycosis, blastomycosis) are less common but important causes of community-acquired pneumonia 1, 8
  • Pneumocystis jirovecii can cause community-acquired pneumonia, especially in immunocompromised patients 1, 7

Diagnostic Considerations

  • Despite current diagnostic techniques, no pathogen is identified in 40-70% of community-acquired pneumonia cases 4, 5

Treatment Implications

  • Empiric treatment should cover the most likely pathogens based on the clinical setting and patient risk factors 1, 7, 2

REFERENCES